BioRap Signs Agreement With HaptoGuard

BioRap Technologies, a private company which manages the commercialization of intellectual property developed by members of the Rappaport Family Institute for Research in the Medical Sciences at the Technion, announced that it has expanded its license and research agreement with HaptoGuard Inc., an American biopharmaceutical company focused on the development and commercialization of anti-inflammatory therapeutics for large, underserved populations.

()a href="http://home.businesswire.com/portal/site/biospace/index.jsp?epi-content=GENERIC&newsId=20050524005415&ndmHsc=v2*A1116327600000*B1116972416000*DgroupByDate*J2*N1000122&newsLang=en&beanID=1229976837&viewID=news_view" target="_blank">BioSpace